FDA asks DNDN for interm result

C

codedeep007

FDA asks DNDN to unblind IMPACT now, absolutely logical

The IMPACT started 4 years ago, should have at least additional 100-200 patients.

DNDN can use this extra 100-200 patient data per FDA to support its claim
 
Congrats to May put buyers who had the balls to make that move. I may buy this at $3. I'm stuck holding some other shit biotech's though like AVNR and ACUS specifically. F me!
 
You must log in or register to reply here.
Back
Top